FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:36-42 July 4, 2002 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Boeckh, M. PubMed Citation

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the author's clinical recommendations.

A 35-year-old man who had undergone allogeneic hematopoietic-cell transplantation two years earlier for acute myeloid leukemia recently moved to a new town. He comes in for a general checkup because he tires easily and has frequent bouts of sinusitis. Physical examination reveals small central cataracts, some patches of vitiligo, and a dry mouth. Blood counts and the results of chemical analyses are . . . [Full Text of this Article]

The Clinical Problem

Strategies and Evidence

Graft-versus-Host Disease

Immunologic Dysfunction

Endocrine Dysfunction

Secondary Cancers

Late Effects of Conditioning Regimens or Prophylaxis against GVHD

Areas of Uncertainty

Guidelines

Conclusions and Recommendations

Source Information

From the Adult Oncology Stem Cell Transplantation Program, Department of Adult Oncology, Dana–Farber Cancer Institute, and the Department of Medicine, Brigham and Women's Hospital — both in Boston.

Address reprint requests to Dr. Antin at the Department of Medicine, Brigham and Women's Hospital, 44 Binney St., Boston, MA 02115.

Related Letters:

Long-Term Care after Hematopoietic-Cell Transplantation in Adults
Boeckh M., Nichols W. G., Marr K. A., Antin J. H.
Extract | Full Text | PDF  
N Engl J Med 2002; 347:1625-1626, Nov 14, 2002. Correspondence

This article has been cited by other articles:

• Einsele, H., Reusser, P., Bornhauser, M., Kalhs, P., Ehninger, G., Hebart, H., Chalandon, Y., Kroger, N., Hertenstein, B., Rohde, F., for the EBMT Working Group on Infectious Disease, (2006). Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantation. Blood 107: 3002-3008 [Abstract] [Full Text]  
• Bolanos-Meade, J., Jacobsohn, D. A., Margolis, J., Ogden, A., Wientjes, M. G., Byrd, J. C., Lucas, D. M., Anders, V., Phelps, M., Grever, M. R., Vogelsang, G. B. (2005). Pentostatin in Steroid-Refractory Acute Graft-Versus-Host Disease. JCO 23: 2661-2668 [Abstract] [Full Text]  
• Reddy, V., Iturraspe, J. A., Tzolas, A. C., Meier-Kriesche, H.-U., Schold, J., Wingard, J. R. (2004). Low dendritic cell count after allogeneic hematopoietic stem cell transplantation predicts relapse, death, and acute graft-versus-host disease. Blood 103: 4330-4335 [Abstract] [Full Text]  
• Bhushan, V., Collins, R. H. Jr (2003). Chronic Graft-vs-Host Disease. JAMA 290: 2599-2603 [Full Text]  
• WESTBROOK, S. D., PAUNOVICH, E. D., FREYTES, C. O. (2003). Adult hemopoietic stem cell transplantation. Journal of the American Dental Association 134: 1224-1231 [Abstract] [Full Text]  
• Boeckh, M., Nichols, W. G., Marr, K. A., Antin, J. H. (2002). Long-Term Care after Hematopoietic-Cell Transplantation in Adults. NEJM 347: 1625-1626 [Full Text]